Medicines made of blood to be produced in Tomsk from 2017; 8 bln rubles to be invested in project


Medicines made of blood will be produced in Tomsk branch of "Microgen" from 2017, said the head of the branch Alexander Koltunov to reporters. It is planned to invest 8 billion rubles in the project, said the Deputy Governor Andrey Antonov.

"The deadlines are quite tight (2015-2017). This is a very big project, an intense work is under way, and the project is being developed. According to the order of the government, new production facilities will be located in "Microgen" in Tomsk," said Koltunov.

According to him, the processing of 300 tons of plasm per year will reduce the dependence on imports and will supply Russians with the vital medicines, such as immunoglobulin, albumin and interferon. "Technology transfer is planned as well. The list of drugs is to be specified," added the head of the branch.

"This issue has been approved by (Deputy Prime Minister) Arkady Dvorkovich, Andrey Antonov told reporters, commenting on the production project. This idea is part of the project "INO Tomsk", we will be supporting it. The production is being developed, thus will be addressed the issues of high-performance workplaces and import substitution."

"Microgen" is the only Russian large producer of bacteriophage. It produces more than 350 types of medicines. The Research and Production Association "Virion", the company`s branch in Tomsk, produces more than 40 types of medicines. The overall production is more than 9 million vaccine packages per year. For three years, 326 million rubles were invested in the production modernization in Tomsk.

Text and pictures by TASS